In a groundbreaking decision, the FDA has lifted the black box warnings on hormone replacement therapy for menopause, potentially improving access for women seeking relief from menopausal symptoms.
The FDA has removed black box warnings on estrogen treatments for menopause, igniting a debate about the benefits and risks of hormone therapy. Dr. Marty Makary discusses the implications for women's health.
Two biotech companies are developing groundbreaking gene therapies that could lead to a single injection for weight loss and blood sugar control. Initial tests show promising results in mice, with human trials on the horizon.
A quiet revolution is taking place as women turn to low-dose testosterone for renewed energy and libido. Discover how this trend is reshaping wellness and relationships, and the cultural implications behind it.
Discover how women are turning to testosterone therapy for renewed energy, improved libido, and overall wellness, despite the FDA's approval challenges and potential side effects.
Isabel Kallman grapples with perimenopause symptoms and the decision to consider hormone therapy. Experts argue that the risks associated with treatment may have been overstated, calling for a reevaluation of FDA warnings.
Menopause can bring disruptive symptoms, but hormone therapy offers relief. Experts discuss its benefits and risks, urging women to make informed decisions about their treatment options.
Doctors are pushing the FDA to remove black box warnings on low-dose estrogen treatments, arguing it discourages women from beneficial hormone therapies for menopause. Experts claim the risks are overstated and can hinder treatment.
In a controversial 6-3 ruling, the Supreme Court has upheld Tennessee's law prohibiting certain medical treatments for transgender minors, which could pave the way for similar bans in 24 other states. The decision has sparked fierce debates about transgender rights and healthcare access for youth across the nation.
In a landmark decision, the US Supreme Court has upheld Tennessee's ban on gender transition care for minors, marking a significant shift in transgender healthcare rights. The ruling, which could influence similar laws across 25 states, has sparked intense debate and dissent among justices.